Annick Desjardins, MD, FRCPC
Duke University · Preston Robert Tisch Brain Tumor Center at Duke University Medical Center · Duke Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Annick Desjardins, MD, FRCPC as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:08 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04547777 · Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant GliomaDarell Bigner · recruiting · Glioma, Malignant · principal investigator
- Ph2NCT03688178 · DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without VarlilumabAnnick Desjardins, MD · active not recruiting · Glioblastoma · principal investigator
- Ph2NCT02540161 · Phase 2 Study of Sym004 for Adult Patients With Recurrent GlioblastomaAnnick Desjardins · completed · Malignant Glioma · principal investigator
- Ph1NCT02303678 · D2C7 for Adult Patients With Recurrent Malignant GliomaDarell Bigner · completed · Malignant Glioma, Brain Tumor, Recurrent · principal investigator
- Ph1NCT01989052 · Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent GliomaAnnick Desjardins · terminated · Malignant Glioma (WHO Grade III or IV) · principal investigator
- Ph1NCT01954030 · Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab FailureAnnick Desjardins · terminated · Malignant Glioma (WHO Grade III or IV) · principal investigator
- Ph2NCT01740258 · Bevacizumab Beyond Progression (BBP)Duke University · completed · Malignant Glioma, Grade 4 Malignant Glioma, Glioblastoma · principal investigator
- Ph2NCT01186406 · Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)Duke University · terminated · Glioblastoma Multiforme, Gliosarcoma · principal investigator
- Ph2NCT01017653 · Panitumumab and Irinotecan for Malignant GliomasAnnick Desjardins · terminated · Malignant Glioma of Brain · principal investigator
- Ph2NCT01004874 · Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for GlioblastomaDuke University · completed · Malignant Glioma, Glioblastoma, Gliosarcoma · principal investigator
- Ph1NCT00979173 · Pharmacokinetics (PK) Study of AC480 for Recurrent GliomaAnnick Desjardins · completed · Glioma · principal investigator
- Ph2NCT00953121 · Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG)Annick Desjardins · completed · Malignant Glioma · principal investigator
- Ph2NCT00735436 · A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)Duke University · terminated · Malignant Glioma, Glioblastoma Multiforme, Gliosarcoma · principal investigator
- Ph2NCT00615927 · Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)Duke University · completed · Glioblastoma, Gliosarcoma · principal investigator
- Ph1NCT00613054 · Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant GliomaAnnick Desjardins · completed · Glioblastoma, Gliosarcoma · principal investigator
- Ph1NCT00609999 · Ph I Dasatinib + Erlotinib in Recurrent MGDuke University · completed · Glioblastoma, Gliosarcoma · principal investigator
- Ph2NCT00597402 · Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and GliosarcomasDuke University · completed · Glioblastoma, Gliosarcoma, Brain Tumor · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:08 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioblastoma.